DarioHealth expands U.S. top-five insurer deal with hypertension program

The added cardiometabolic offering could roughly triple Dario’s revenue opportunity with that customer, with revenue expected in 2026 and greater impact from 2027 onward.

Summary

verifying reliability

Terms & Concepts

No specialized terms available for this topic.